To the full analysis
BioGaia stock: growth
BIOG-B.STBioGaia reported $154.23M in revenue for fiscal 2025, up 8.1% on the prior year, up 15.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
16.3%
per year from 2006 to 2025, per share 15.3%
Earnings (Annual rate)
28.8%
per year from 2006 to 2025, per share 27.6%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 15.5% | 12.3% | 16.3% |
| Revenue per share | 15.5% | 10.5% | 15.3% |
| Earnings | 13.1% | 10.6% | 28.8% |
| Earnings per share | 13.1% | 8.9% | 27.6% |
| Free cash flow | 8.1% | 13.0% | no data |
| Free cash flow per share | 8.1% | 11.2% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $8.7M | $272.74K | −$190.82K |
| 2007 | $10.69M | $1.97M | $309.14K |
| 2008 | $14.56M | $3.62M | $1.69M |
| 2009 | $20.4M | $3.61M | $5.05M |
| 2010 | $23.67M | $4.73M | $6.85M |
| 2011 | $31.58M | $7.66M | $5.68M |
| 2012 | $64.7M | $32.79M | $30.7M |
| 2013 | $31.67M | $6.19M | $6.2M |
| 2014 | $48.31M | $14.78M | $10.02M |
| 2015 | $48.46M | $12.17M | $8.98M |
| 2016 | $53.61M | $22.82M | $14.27M |
| 2017 | $61.67M | $18.11M | $19.65M |
| 2018 | $74.39M | $21.55M | $17.01M |
| 2019 | $77.04M | $18.79M | $10.91M |
| 2020 | $74.91M | $18.02M | $20.57M |
| 2021 | $78.72M | $19.68M | $21.61M |
| 2022 | $110.7M | $37.48M | $30.18M |
| 2023 | $130M | $36.63M | $37.83M |
| 2024 | $142.66M | $35.23M | $36M |
| 2025 | $154.23M | $33.37M | $30.38M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 12 Dec 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.